Clinical Study of mRNA Vaccine in Patients With Advanced Malignant Solid Tumors

Condition:   Advanced Malignant Solid Tumors Intervention:   Biological: Neoantigen mRNA Personalised Cancer vaccine Sponsors:   Stemirna Therapeutics;   Peking University Cancer Hospital & Institute Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials